GlassScriptPhysician profile
Amir Ali Khan
NPI 1699180950
$14,669.14
in general payments reported to CMS, 2019-2025
6 companies · $47.17 in 2025
The $47.17 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12K · 2022: $551 · 2023: $1,682 · 2024: $148 · 2025: $47.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $877.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,126.42 | 2021-2024 | Davinci Xi, Da Vinci Surgical System |
| Endogastric Solutions, INC | $170.33 | 2023 | Esophyx |
| Medtronic, INC. | $156.25 | 2022-2023 | Signet |
| Davol INC. | $149.99 | 2023 | Phasix Mesh |
| Abbott Laboratories | $47.17 | 2025 | Perclose Prostyle, Perclose Proglide |
| Takeda Pharmaceuticals U.S.A., INC. | $18.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.